IASR Vol.47 No.4 (No. 554) April 2026 Rubella and congenital rubella syndrome in Japan, as at February 2026

PDF download（PDF：702KB）

Rubella and congenital rubella syndrome in Japan, as at February 2026

International framework for rubella elimination verification, achievement of elimination in Japan, and future challenges
Progress toward rubella elimination verification in Japan: from vaccination targeting girls to additional measures for adult men in Japan
Detection of endogenous control (human RNase P RNA) in measles and rubella testing
External quality control of measles and rubella testing (nucleotide sequencing and genotyping analysis)
Implementation status of routine immunization with rubella-containing vaccines: first, second, and fifth stages in Japan
Rubella vaccination coverage and seroprevalence in fiscal year 2025: preliminary results from the FY 2025 National Epidemiological Surveillance of Vaccine-Preventable Diseases
Workplace-based initiatives for rubella prevention
Effectiveness and safety analysis using Japan’s national vaccination database
Assessment of the need for laboratory confirmation in mumps surveillance: findings from a study in Kanazawa City, Ishikawa Prefecture